Skip to main content
BC Innovations
Feature Story

Genentech stays the course

How Genentech has refined its preclinical process

By Selina Koch, Staff Writer

While other pharmas are increasingly sourcing innovation through academic partnerships to bolster their pipelines, Roche's Genentech Inc. unit believes its best strategy for staying ahead is to hire and grow the best scientists in-house, and that the key to preclinical success is to bring in clinical and marketing input from the get-go.

Sara Kenkare-Mitra, SVP of development sciences at Genentech, told BioCentury that over the past decade, the company's decision-making processes have become faster and more rigorous by toppling silos and building a model to seamlessly integrate its various preclinical and clinical teams from the earliest stages of drug development.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial

Management Updates

There were no items published for this section in the most recent issue. Click more >> to read previously published items.

Preclinical Results

There were no items published for this section in the most recent issue. Click more >> to read previously published items.